Us Tumor Blood Testing Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Tumor Blood Testing Market was valued at USD 4.2 Billion in 2022 and is projected to reach USD 10.5 Billion by 2030, growing at a CAGR of 12.0% from 2024 to 2030.
US Tumor Blood Testing Market Sees Rapid Growth Amid Advances in Liquid Biopsy Technology
The US tumor blood testing market is witnessing remarkable growth, driven by the increasing demand for non-invasive cancer diagnostics and advancements in liquid biopsy technology. In 2024, the market is projected to be worth $3.25 billion, with an expected rise to $5.26 billion by 2032, growing at a CAGR of 19.38%.
Key Drivers of Market Growth
Rising Cancer Prevalence: Over 1.9 million new cancer cases were diagnosed in the US in 2024, increasing the demand for efficient and early detection methods.
Technological Innovations: Next-Generation Sequencing (NGS) and Digital PCR are revolutionizing tumor blood testing by providing high sensitivity and specificity.
Regulatory Approvals: The FDA's recent approvals for liquid biopsy tests have fueled market expansion.
Shift Towards Personalized Medicine: Tumor blood tests enable oncologists to tailor treatments based on a patient's genetic profile.
Market Segmentation and Emerging Trends
Biomarker Type: Circulating Tumor DNA (ctDNA) and Circulating Tumor Cells (CTCs) are the most utilized biomarkers.
Sample Type: Plasma-based tests dominate the market due to ease of collection and high biomarker stability.
Application Areas: Cancer diagnosis, prognosis, and treatment monitoring are primary areas of application.
Competitive Landscape
Major players, including Guardant Health, Roche, Illumina, and Thermo Fisher Scientific, are heavily investing in R&D to develop advanced liquid biopsy tests. Guardant Health's Guardant360 and Roche’s FoundationOne CDx are leading tumor blood tests that offer comprehensive genomic profiling.
Challenges and Future Outlook
Despite rapid growth, challenges such as high test costs, insurance reimbursement hurdles, and the need for standardized protocols persist. However, with government initiatives promoting cancer diagnostics and technological advancements improving test accuracy, the market is poised for continued expansion.
Moreover, the increasing adoption of tumor blood tests in emerging areas, including home-based diagnostics, could further accelerate market penetration. In comparison, the 100 Gigabit Fiber Optic Transceiver Market is also experiencing significant growth due to rising demand for high-speed data transmission, reflecting the broader trend of technological advancement across industries.
Get an In-Depth Research Analysis of the Global Tumor Blood Testing Market Size And Forecast [2025-2032]
Guardant Health
Trovagene
Genomic Health
Roche
Bio-Techne
Pathway Genomics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Tumor Blood Testing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Tumor Blood Testing Market
Circulating Tumor DNA (ctDNA) Tests
Circulating Tumor Cells (CTCs) Tests
Exosome-based Tests
Protein-based Biomarkers Tests
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Melanoma
Early Detection
Monitoring Treatment Response
Recurrence Monitoring
Prognosis
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Mass Spectrometry
Liquid Biopsy Technology
Hospitals
Diagnostic Laboratories
Research Institutes
Oncology Clinics
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Tumor Blood Testing Market Research Analysis
1. Introduction of the Global Tumor Blood Testing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Tumor Blood Testing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Tumor Blood Testing Market, By Type
6. Global Tumor Blood Testing Market, By Application
7. Global Tumor Blood Testing Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Tumor Blood Testing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/